share_log

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K: Current report

Intelligent Bio Solutions | 8-K:重大事件
美股sec公告 ·  05/03 16:35
Moomoo AI 已提取核心訊息
Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 29, 2024. The report indicates that as a result of recent common stock issuances and the exercise of outstanding warrants, the total number of outstanding shares of the company's common stock has reached 3,117,049 as of the close of business on the reported date. The company, identified as an emerging growth company, has not elected to use the extended transition period for complying with new or revised financial accounting standards. The filing, signed by Spiro Sakiris on May 3, 2024, also includes an interactive data file for the cover page within the Inline XBRL document.
Intelligent Bio Solutions Inc., a Delaware-incorporated company listed on The Nasdaq Stock Market under the trading symbol INBS, has filed a Form 8-K with the United States Securities and Exchange Commission on April 29, 2024. The report indicates that as a result of recent common stock issuances and the exercise of outstanding warrants, the total number of outstanding shares of the company's common stock has reached 3,117,049 as of the close of business on the reported date. The company, identified as an emerging growth company, has not elected to use the extended transition period for complying with new or revised financial accounting standards. The filing, signed by Spiro Sakiris on May 3, 2024, also includes an interactive data file for the cover page within the Inline XBRL document.
Intelligent Bio Solutions Inc. 是一家在納斯達克股票市場上市的特拉華州註冊公司,交易代碼爲INBS,已於2024年4月29日向美國證券交易委員會提交了8-K表格。報告顯示,由於最近發行普通股和行使未償認股權證,截至報告日營業結束時,公司普通股的已發行總股數已達到3,117,049股。該公司被認定爲新興成長型公司,並未選擇使用延長的過渡期來遵守新的或修訂的財務會計準則。該文件由斯皮羅·薩基里斯於2024年5月3日簽署,還包括Inline XBRL文檔封面頁的交互式數據文件。
Intelligent Bio Solutions Inc. 是一家在納斯達克股票市場上市的特拉華州註冊公司,交易代碼爲INBS,已於2024年4月29日向美國證券交易委員會提交了8-K表格。報告顯示,由於最近發行普通股和行使未償認股權證,截至報告日營業結束時,公司普通股的已發行總股數已達到3,117,049股。該公司被認定爲新興成長型公司,並未選擇使用延長的過渡期來遵守新的或修訂的財務會計準則。該文件由斯皮羅·薩基里斯於2024年5月3日簽署,還包括Inline XBRL文檔封面頁的交互式數據文件。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息